Veterinary oncology is a specialized field of veterinary medicine focused on the diagnosis, treatment, and management of cancer in animals. It encompasses various approaches including surgery, chemotherapy, radiation therapy, and emerging treatments such as immunotherapy and targeted therapies. As cancer is a leading cause of illness and death among companion animals, particularly aging pets, veterinary oncology plays a critical role in extending and improving their quality of life. Advances in diagnostic tools and therapeutics, along with increasing awareness among pet owners, are driving growth in this field. 

The growth of the veterinary oncology market is driven by several key factors, including the rising prevalence of cancer in pets, particularly among aging dogs and cats. As pets live longer, the likelihood of developing cancer increases, leading to greater demand for specialized treatment. Additionally, advancements in veterinary medicine, such as improved diagnostic tools and innovative therapies, are enhancing treatment outcomes and driving market expansion. Increased awareness among pet owners about the availability of cancer treatments, combined with growing investments in research and development, further supports market growth. The rising number of clinical trials and partnerships aimed at developing new oncology therapies also contribute to the market’s evolution, ensuring better access to cutting-edge care for animals.

The veterinary oncology market faces several challenges that can impact its growth and accessibility. One of the primary hurdles is the high cost of cancer treatments, which can be prohibitively expensive for many pet owners, limiting access to necessary care. Additionally, there is a shortage of specialized veterinary oncologists and limited availability of advanced treatment centers, particularly in rural areas, making it difficult for pet owners to access expert care. The complexity of diagnosing and treating cancer in animals, along with the lack of widespread awareness about available therapies, further exacerbates these challenges.

Elanco, Boehringer Ingelheim International GmbH, Zoetis, Elekta AB, PetCure Oncology, Accuray Incorporated, Varian Medical Systems, Inc. (parent company: Siemens Healthineers), Virbac, Merck & Co., Inc., Ardent Animal Health, LLC.

By Animal Type: Based on the Animal Type, Global Veterinary Oncology Market is segmented as; Canine, Feline, Equine.

By Therapy: Based on the Therapy, Global Veterinary Oncology Market is segmented as; Radiotherapy, Surgery, Chemotherapy, Immunotherapy, Other Therapies.

By Cancer Type: Based on the Cancer Type, Global Veterinary Oncology Market is segmented as; Skin Cancers, Lymphomas, Sarcomas, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe and Middle East & Africa.

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.